Iron-dependent DNA-cleavage-associated colorimetric response
Biochemical assay · Double-stranded DNA-functionalized gold nanoparticles in a cell-free assay [1]
Iron(II)-supplemented Blenoxane retained the dispersed red nanoparticle signal, whereas water, iron alone and bleomycin alone showed aggregation-associated color change. Model abasic and protruding-end substrates supported the proposed cleavage-sensitive readout; this remains an indirect assay of DNA cleavage.
| Endpoint | Reported result | Reference |
|---|---|---|
| Colloidal stability after iron-supplemented Blenoxane treatment | qualitative result Red dispersion retained with Fe(II)·BLM/Blenoxane; water, Fe2+ alone and BLM alone aggregated with a red-to-purple change. | [1] |
| Cleavage-pathway model controls | qualitative result Intact and abasic model substrates aggregated; the protruding-end model retained dispersion. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 62 µmol·L−1 bleomycin in Figure 3 and Blenoxane in Figure 6; treatment concentration, not IC50.
- Exposure duration
- Results describe 10 min at 20–25 °C for visual evaluation following salt addition.
- Method
- Color observation and UV-visible spectroscopy of DNA-coated gold nanoparticles.
- Vehicle
- Aqueous phosphate-buffered nanoparticle dispersion; water substitution control.
- Co-treatment
- Fe(II) supplementation; inactive BLM and Fe2+-only controls.
- Reported limits
- Exact final-volume and nanoparticle concentration reconstruction is withheld: the general assay methods contain inconsistent volume/unit statements. No assay recipe, potency or kinetic parameter is inferred. Replicate n for Figures 3/6 is not specified in their captions.
Methods and source locations
Compound reported in the paper: Blenoxane (bleomycin A2/B2 mixture)
Evidence for the named Blenoxane mixture under Fe(II) supplementation; no sulfate-specific effect, individual-congener potency or Adooq lot validation.
Materials; colorimetric assay methods; Results and Discussion, Figures 3, 5 and 6
Colloidal stability after iron-supplemented Blenoxane treatment: Visual color and UV-visible comparison; Figure 6 identifies the Blenoxane mixture separately from BLM A5. — Results and Discussion, Figures 3a-b and 6; Materials
Cleavage-pathway model controls: Engineered substrate-control comparison; supports an indirect cleavage interpretation, not direct identification of cleavage products. — Results and Discussion, Figure 5 and Conclusion